Jove
Visualize
Contact Us

Related Concept Videos

Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

264
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
264
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

305
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
305
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

301
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
301
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

402
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
402
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

229
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
229
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

363
A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
363

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacist-driven antimicrobial stewardship: evolving roles in clinical practice.

Journal of pharmaceutical health care and sciences·2026
Same author

Foreword.

Biological & pharmaceutical bulletin·2026
Same author

Risk Factor of Persistent Hypotension Associated with 5-Aminolevulinic Acid: A Single-Institution Retrospective Study.

Biological & pharmaceutical bulletin·2026
Same author

Impact of immunotherapy on survival and treatment patterns of patients with extensive-stage small cell lung cancer: a study using a Japanese nationwide database.

Future oncology (London, England)·2026
Same author

MicroRNA-based discrimination of hepatotoxic and non-hepatotoxic drugs using a humanized liver mouse model.

Toxicology letters·2026
Same author

Development and practical validation of BUBBLESS tapping instrument for efficient bubble removal during antibody drug mixing.

Journal of pharmaceutical health care and sciences·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 3, 2026

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.9K

Clinical Feasibility of Nomogram-Based Vancomycin Dosing Strategy: A Retrospective Study.

Naoto Okada1, Toshiki Yoshii1, Miho Tamura1

  • 1Pharmacy Department, Yamaguchi University Hospital.

Biological & Pharmaceutical Bulletin
|March 1, 2026
PubMed
Summary

A vancomycin (VCM) nomogram effectively guides dosing to achieve therapeutic drug levels, improving patient outcomes. This approach offers a practical alternative to complex software for optimizing VCM therapy.

Keywords:
area under the concentration–time curvenomogramtherapeutic drug monitoringvancomycin

More Related Videos

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
11:28

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

Published on: September 9, 2015

29.9K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K

Related Experiment Videos

Last Updated: Mar 3, 2026

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.9K
A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
11:28

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

Published on: September 9, 2015

29.9K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Infectious Diseases

Background:

  • Therapeutic drug monitoring of vancomycin (VCM) is crucial for optimizing efficacy and safety.
  • Area under the concentration-time curve (AUC)-guided dosing is recommended but often limited by software availability.
  • Alternative dosing strategies are needed for routine clinical practice.

Purpose of the Study:

  • To evaluate the utility of an AUC-guided nomogram as an alternative VCM dosing strategy.
  • To compare pharmacokinetic target attainment and safety outcomes between nomogram-based, software-based, and non-intervention VCM dosing.
  • To assess the impact of VCM dosing strategies on clinical outcomes in patients with Gram-positive bacteremia.

Main Methods:

  • Retrospective study of hospitalized patients receiving VCM.
  • Patients categorized into software-guided, nomogram-guided, or non-intervention dosing groups.
  • Comparison of first-day AUC (AUCf24) attainment, safety outcomes (acute kidney injury), and time to C-reactive protein reduction.

Main Results:

  • The nomogram group achieved target AUCf24 attainment (55.4%) significantly more often than the non-intervention group (30.8%) and comparably to the software group (62.0%).
  • Non-intervention dosing was associated with failure to achieve target AUCf24 (OR, 2.82).
  • No significant difference in acute kidney injury incidence was observed. Patients with Gram-positive bacteremia in the nomogram and software groups showed a faster reduction in C-reactive protein compared to the non-intervention group.

Conclusions:

  • A nomogram-based VCM dosing strategy facilitates achievement of therapeutic VCM exposure.
  • Nomogram dosing is a feasible and effective alternative to software-based strategies in clinical practice.
  • Optimized VCM dosing may improve clinical response in patients with Gram-positive infections.